Aadi Bioscience, Inc. (AADI) reported Q3 EPS of ($0.68), $0.09 better than the analyst estimate of ($0.77). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $3.11 million.
Aadi Bioscience, Inc. (AADI) reported Q3 EPS of ($0.68), $0.09 better than the analyst estimate of ($0.77). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $3.11 million.